Radioiodine in Low-Risk Thyroid Cancer | NEJM

1 Views
administrator
administrator
07/06/23

Radioiodine is typically administered after thyroidectomy in patients with thyroid cancer, but its benefits in those with low-risk disease are controversial. New research findings are summarized in a short video.

To see the full article, follow this link: https://nej.md/3HvClQD

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next